Lawsuits Continue To Be Filed Claiming Zantac Causes Cancer

Last week it was breast cancer and now cancer of the colon can allegedly be blamed on the once popular anti-heartburn and acid reflux medication

Tuesday, May 26, 2020 - Heartburn and acid reflux relief drug Zantac is accused of causing cancer in thousands of people, many of whom have hired Zantac Cancer Lawyers and filed a complaint seeking monetary compensation for their actual damages and also pain and suffering. On May 20, a Florida man filed a lawsuit against Sanofi, the maker of Zantac claiming that the company should have known and warned consumers that their product can cause colon cancer. About Lawsuits writes: "The complaint (PDF) was filed by Christopher Montgomery in the U.S. District Court for the Southern District of Florida on May 20, claiming the makers of Zantac intentionally hid the fact that users may be exposed to dangerous levels of N-Nitrosodimethylamine (NDMA), a known cancer-causing chemical." The complaint also maintains: "Put simply, Zantac is a cancerous poison. When ingested, every tablet (and every dose), produces the toxic carcinogen N-Nitrosodimethylamine (NDMA) in the body. NDMA is a by-product or waste product of various industrial processes, including the manufacture of rocket fuel. NDMA's lone medical use is to cause cancer in animals for laboratory experimentation," according to About Lawsuits. Others have filed lawsuits alleging that they have developed stomach, bladder, prostate, esophageal, breast, Colo-rectal, and other forms of cancer from using Zantac regularly and for a long time.

The US FDA recently demanded that Sanofi withdraw Zantac from the market due to the cancer scare. Plaintiff lawyers allege improperly storing the tablets at higher than regular room temperatures can cause the level of N-Nitrosodimethylamine (NDMA) to skyrocket to carcinogenic levels, and that customer's existing supplies of the product should be discarded or returned to the pharmacy where it was purchased. Doctors are forbidden to prescribe Zantac until further notice. NDMA is given to laboratory animals to induce tumors. Other experts think that the levels of NDMA increase when it is mixed with nitrites in the stomach, presumably from the meat that was eaten causing heartburn in the first place. Zantac users are urged to switch medications to others like Pepcid which has not tested positive for NDMA and to make lifestyle and dietary changes. The FDA warning states "The medicines are being recalled because they may contain unacceptable levels of N-nitrosodimethylamine (NDMA). FDA has advised companies to recall their ranitidine if testing shows levels of NDMA above the acceptable daily intake (96 nanograms per day or 0.32 parts per million for ranitidine."

Government Health Agencies from other countries are following the lead of the US FDA and banning Zantac from sale until further testing to link the drug to developing cancer. According to England's Daily Mail, "Zantac and other heartburn and acid-reflux drugs have been pulled from the market and British physicians may not prescribe any form of Zantac- a popular heartburn and indigestion drug over fears they may cause cancer."

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.